Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
absence, added, analogy, Appeal, articular, Austria, authoritative, bankruptcy, blended, Canadian, characterized, Colbar, Commonwealth, confusingly, cooperated, copy, covenant, denial, denied, denominated, direct, Egypt, EVOLENCE, exploring, FAS, fastest, feature, FSP, Germany, goal, Goodwill, hardware, hierarchy, highest, Hungary, identical, incremental, injunctive, installment, intra, introduction, Italy, Lifescience, literature, merit, NE, network, nonfinancial, observable, opposition, ORTHOVISCmini, ORTHOVISC®mini, petition, Plasmaconcept, platform, population, pressure, quoted, ratified, rational, receivedConformit, recession, relationship, repayment, reply, requesting, retrospectively, Rivex, Room, sample, satisfaction, scheduled, secondary, shortly, Street, substantive, turmoil, unobservable, variable, viewed, Washington
Removed:
accomplished, achieving, Additionally, APB, avian, back, cancelled, code, consecutive, CTA, decided, division, driver, Ferrer, filling, forfeiture, Grupo, index, initially, nature, OBP, originally, outsource, overstocking, Pharmaren, presently, prohibit, provoke, purification, regular, renewable, representing, revert, subsequently, target, taxable, team, tied, twelve, unclear
Filing tables
Filing exhibits
Related press release
ANIK similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-06275, 333-66831, 333-79047, 333-58264 and 333-110326) of Anika Therapeutics, Inc. of our report dated March 9, 2009 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 9, 2009